Compare · DD vs MBII
DD vs MBII
Side-by-side comparison of DuPont de Nemours Inc. (DD) and Marrone Bio Innovations Inc. (MBII): market cap, price performance, sector, and recent activity on the wire.
Summary
- DD operates in Industrials, while MBII operates in Basic Materials - the two are in different parts of the market.
- DD carries a market cap of $19.90B.
- DD has hit the wire 14 times in the past 4 weeks while MBII has been quiet.
- DD has more recent analyst coverage (25 ratings vs 2 for MBII).
- Company
- DuPont de Nemours Inc.
- Marrone Bio Innovations Inc.
- Price
- -
- -
- Market cap
- $19.90B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2017
- 2013
- News (4w)
- 14
- 0
- Recent ratings
- 25
- 2
DuPont de Nemours Inc.
DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company's Electronics & Imaging segment supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits addressing front-end and back-end of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, electroless, and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for liquid crystal displays, advanced-matrix organic light emitting diode, and quantum dot applications. The Transportation & Advanced Polymers segment provides engineering resins, adhesives, silicones, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets. Its Safety & Construction segment provides engineered products and integrated systems for worker safety, water purification and separation, aerospace, energy, medical packaging, and building materials. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. is based in Wilmington, Delaware.
Marrone Bio Innovations Inc.
Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Davis, California.
Latest DD
- DuPont announces first OxyMem™ MABR installation in the United States
- Director Breen Edward D gifted 18,945 shares, decreasing direct ownership by 15% to 108,331 units (SEC Form 4)
- DuPont Announces Collaboration with Microsoft and NobleAI to Accelerate R&D Innovation with AI
- SEC Form SCHEDULE 13G filed by DuPont de Nemours Inc.
- SVP & General Counsel Hoover Erik T. exercised 4,203 shares at a strike of $108.84 and sold $633,896 worth of shares (4,203 units at $150.82) (SEC Form 4)
- CEO Koch Lori exercised 2,311 shares at a strike of $108.84 and sold $349,308 worth of shares (2,311 units at $151.15) (SEC Form 4) (for withholding tax)
- Director Breen Edward D received a gift of 35,551 shares, exercised 89,845 shares at a strike of $108.84 and sold $13,154,206 worth of shares (89,845 units at $146.41), increasing direct ownership by 39% to 127,276 units (SEC Form 4) to satisfy withholding obligation
- DuPont Launches High-Flow Electrodeionization Modules for Higher-Purity Water Applications
- SEC Form 144 filed by DuPont de Nemours Inc.
- Universal Corporation Announces Appointment of Gregory R. Friedman to Board of Directors
Latest MBII
- ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions
- Shares of chemicals companies are trading lower amid economic uncertainty following a bearish outlook from FedEx. An economic slowdown could weigh on end markets for chemicals and materials.
- SEC Form 15-12G filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form EFFECT filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.
- SEC Form S-8 POS filed by Marrone Bio Innovations Inc.